EASTPHARMA LTD.
London, 29 April 2015 - EastPharma (EAST LI) informs that it will be releasing its Q1 2015 sales performance and a review of its main subsidiary DEVA Holding's financial statements for the related period on 7 May 2015.
A conference call to review the financial performance for the period 31 March 2015 will be hosted by the management of EastPharma at 1:45pm London time on 8 May 2015(8:45am New York / 2:45pm Zurich time / 3:45pm Istanbul time). The dial-in details are provided below.
Conference call:
Dial-in Number (UK): + 44 (0)20 7162 0077
Dial-in Number (US): + 1 334 323 6201
Dial-in Number (Switzerland): + 41 (0)434 5692 61
Dial-in Number (Germany): + 49 (0)695 8999 0507
Conference ID: 952999
For further information, please contact:
Investor Relations:
email: ir@eastpharmaltd.com
EastPharma Ltd - a company active in the manufacturing and marketing of pharmaceutical products in Turkey and in other regional markets; for further information please visit www.eastpharmaltd.com.